What's new? Log in Free sign up

Filing search / Iovance Biotherapeutics, Inc. / "Hedging"

Search information

Iovance Biotherapeutics, Inc.

Companies

"Hedging"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

69 results

Newest first Best match first

IOVA Iovance Biotherapeutics, Inc.

into hedging agreements. While hedging agreements, such as currency options and forwards and interest rate swaps, may limit some of the exposure to exchange … consideration in the scope of ASC Topic 815, Derivatives and Hedging, is included in the cost of the asset acquisition at its acquisition date fair value

27 Feb 25

5:15pm

IOVA Iovance Biotherapeutics, Inc.

the Company’s securities, long positions, such as options to buy the Company’s securities, and hedging positions. For purposes of this policy, a “hedging … not enter into hedging or monetization transactions or similar arrangements with respect to Company securities. “Covered Persons” include: each

27 Feb 25

5:15pm

IOVA Iovance Biotherapeutics, Inc.

Quarterly report

as of September 30, 2024. Contingent consideration in the scope of ASC Topic 815, Derivatives and Hedging (“ASC 815”), is included in the cost … of the acquired intangible assets on a relative fair value basis. Contingent consideration in the scope of ASC Topic 815, Derivatives and Hedging, is included

7 Nov 24

5:15pm

IOVA Iovance Biotherapeutics, Inc.

Quarterly report

, Derivatives and Hedging (“ASC 815”), is included in the cost of the asset acquisition at its acquisition date fair value. Contingent consideration … on a relative fair value basis. Contingent consideration in the scope of ASC Topic 815, Derivatives and Hedging, is included in the cost of the asset

8 Aug 24

5:10pm

IOVA Iovance Biotherapeutics, Inc.

Quarterly report

of ASC Topic 815, Derivatives and Hedging (“ASC 815”), is included in the cost of the asset acquisition at its acquisition date fair value. Contingent … in the scope of ASC Topic 815, Derivatives and Hedging, is included in the cost of the asset acquisition at its acquisition date fair value

9 May 24

5:10pm

Definitive proxy

29 Apr 24

5:06pm

3y0qbhlfsvez4emk 7m

Departure of Directors or Certain Officers

qh58ysaa2wura40

28 Feb 24

5:15pm

28 Feb 24

5:15pm

Prospectus supplement for primary offering

zefhhfy3m 863jbhd

Quarterly report

7 Nov 23

5:15pm

Quarterly report

8 Aug 23

5:15pm

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Financial Statements and Exhibits

Definitive proxy

26 Apr 23

5:15pm

Preliminary revised proxy

19 Apr 23

5:19pm

Preliminary proxy

14 Apr 23

5:00pm

8tw gexh6ntmj801v8i8

Amendments to Articles of Incorporation or Bylaws

Definitive proxy

27 Apr 22

5:02pm

Prev
1
2
3
4
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.